Empresa Intervacc AB (publ) Nasdaq Stockholm
Acciones
SE0009607252
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Novel Veterinary Vaccines
100,0
%
| 5 | 100,0 % | 10 | 100,0 % | +84,77 % |
Ventas por región
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 5 | 100,0 % | 10 | 100,0 % | +84,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jonas Sohlman
CEO | Chief Executive Officer | - | 21/08/23 |
Jan Persson
DFI | Director of Finance/CFO | - | 06/02/20 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 11/06/20 |
Patrik Hellberg
CIO | Chief Investment Officer | - | - |
Tim Wood
LAW | General Counsel | - | 01/08/18 |
Corporate Officer/Principal | 45 | 01/01/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Boel Sundvall
BRD | Director/Board Member | 65 | 01/01/23 |
Chairman | 56 | - | |
Edwin Torr
BRD | Director/Board Member | 63 | - |
Director/Board Member | 63 | 01/01/09 | |
Bengt Guss
FOU | Founder | 66 | 01/01/01 |
Niels Holcke
BRD | Director/Board Member | - | 01/01/20 |
Michela de Carli
BRD | Director/Board Member | - | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 736 264 | 59 198 500 ( 78,16 %) | 0 | 78,16 % |
Información de la empresa
Intervacc AB
Västertorpsvägen 135 Hägersten
129 44, Stockholm
+46 8 12 01 06 00
http://www.intervacc.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,91 % | 118 mil M | |
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M |